CEO Paul Brennan said; “We welcome the opportunity to work with Al Mofadaly to expand our reach throughout the middle-east. Our NovoSorb BTM will offer patients in the region a significant improvement in their clinical outcomes and enable us to serve our global key opinion leaders”.
Ho ho ho
CEO Paul Brennan said; “We welcome the opportunity to work with...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.44 |
Change
0.000(0.00%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 143 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.35 | 49 | 1 |
View Market Depth
| Last trade - 09.42am 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |
Day chart unavailable